Advertisement
CYH vs THC
Which Stock Would AI Choose? Community Health Systems (CYH) vs. Tenet Healthcare (THC) Stock Comparison
Key Takeaways
- THC commands a much larger market capitalization of approximately $15.8 billion compared to CYH's $396 million, reflecting greater scale in the healthcare sector.
- Both stocks have delivered year-to-date (YTD) gains around 9-10%, but THC shows stronger one-year momentum with a 45% rise versus CYH's modest 5%.
- CYH reported a wider-than-expected Q1 loss amid declining patient volumes, while THC delivered robust prior-quarter profitability.
- Analyst price targets indicate substantial upside for THC (average $263) relative to CYH (average $3.31).
- CYH pursues divestitures to reduce debt, contrasting THC's expansion in ambulatory care services.
- Market sentiment leans toward THC with Buy ratings, while CYH holds a cautious Hold consensus.
Introduction
Community Health Systems (CYH) and Tenet Healthcare (THC) are key players in the U.S. hospital sector, operating acute care facilities amid evolving healthcare dynamics like volume fluctuations and regulatory pressures. This stock comparison analyzes their recent market positioning, performance metrics, and growth trajectories. Traders seeking short-term momentum and long-term investors evaluating healthcare exposure will find value in understanding their relative strengths, such as profitability contrasts and strategic focuses, within the current market environment.
CYH Overview and Recent Performance
Community Health Systems (CYH), headquartered in Franklin, Tennessee, owns and operates general acute care hospitals offering services from emergency care to rehabilitation across multiple states. In recent market activity, CYH shares have traded near the lower end of their 52-week range ($2.38-$4.47), closing around $2.81 with a trailing price-to-earnings (P/E) ratio of 0.82 and earnings per share (EPS) of $3.44. Key influences include Q1 2026 results showing revenue of $2.96 billion but a net loss of $64 million, driven by flagging patient volumes. The company announced divestitures, such as selling Crestwood Medical Center, and a tender offer for senior secured notes to manage debt. These moves have tempered sentiment, with analysts maintaining a Hold rating and an average price target of $3.31.
THC Overview and Recent Performance
Tenet Healthcare (THC), based in Dallas, Texas, provides diversified healthcare services through acute care hospitals, ambulatory surgery centers (ASCs), and specialty facilities emphasizing cardiovascular and neurosciences care. Shares recently closed near $181, within a 52-week range of $122-$247, supported by a P/E ratio of 11.67 and EPS of $15.50. Recent weeks featured some pullbacks amid broader market moves, yet prior-quarter results were strong with $5.53 billion in revenue and $413 million net income. Anticipation for upcoming earnings, coupled with analyst optimism (average price target $263), has bolstered positioning. Strategic growth in ASCs and off-campus emergency departments continues to drive positive relative performance and sentiment.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform’s top-performing AI trading bots, curating 25 elite selections from a total of 351 bots that trade thousands of tickers across diverse strategies. These bots employ varied approaches, including signal agents for short-term trades, virtual agents for pattern recognition, and brokerage agents for automated execution, spanning timeframes from intraday to long-term holds. Selected for their suitability to prevailing market conditions—like volatility in healthcare—they feature strong historical performances tailored to current trends. Tickeron’s hundreds of AI tools offer traders data-driven insights; explore the trending section to identify bots aligning with your strategy for stocks like CYH and THC.
Head-to-Head Comparison
Both CYH and THC focus on acute care hospitals but differ markedly in scale and strategy. THC’s larger footprint enables diversified revenue from ASCs and urgent care, fostering growth drivers absent in CYH’s core hospital model strained by divestitures. Recent momentum favors THC with superior profitability and YTD stability, while CYH grapples with volume risks and debt restructuring. Risk factors include sector-wide reimbursement pressures, but THC exhibits lower volatility and higher market sentiment via elevated analyst targets. Trade-offs highlight THC’s premium valuation against CYH’s depressed multiples offering potential value plays.
Tickeron AI Verdict
Tickeron’s AI analysis currently leans toward THC over CYH, based on greater trend consistency, robust profitability catalysts, and stronger relative positioning with higher analyst upside. Factors like THC’s ambulatory expansion and earnings momentum suggest a higher probability of outperformance in the near term, though both remain tied to healthcare sector dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYH is a Buy and THC is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CYH’s FA Score shows that 1 FA rating(s) are green whileTHC’s FA Score has 1 green FA rating(s).
- CYH’s FA Score: 1 green, 4 red.
- THC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CYH’s TA Score shows that 5 TA indicator(s) are bullish while THC’s TA Score has 4 bullish TA indicator(s).
- CYH’s TA Score: 5 bullish, 4 bearish.
- THC’s TA Score: 4 bullish, 4 bearish.
Price Growth
CYH (@Hospital/Nursing Management) experienced а -1.30% price change this week, while THC (@Hospital/Nursing Management) price change was -0.20% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.10%. For the same industry, the average monthly price growth was +4.78%, and the average quarterly price growth was +27.33%.
Reported Earning Dates
CYH is expected to report earnings on Jul 29, 2026.
THC is expected to report earnings on Jul 16, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-0.10% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| CYH | THC | CYH / THC | |
| Capitalization | 427M | 15.4B | 3% |
| EBITDA | 2.02B | 4.88B | 41% |
| Gain YTD | -2.885 | -10.049 | 29% |
| P/E Ratio | 0.88 | 9.30 | 9% |
| Revenue | 12.3B | 21.9B | 56% |
| Total Cash | 712M | 2.97B | 24% |
| Total Debt | 10.8B | 13.2B | 82% |
CYH | THC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 17 Undervalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 36 | |
SMR RATING 1..100 | 100 | 25 | |
PRICE GROWTH RATING 1..100 | 53 | 63 | |
P/E GROWTH RATING 1..100 | 91 | 67 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CYH's Valuation (17) in the Hospital Or Nursing Management industry is somewhat better than the same rating for THC (78). This means that CYH’s stock grew somewhat faster than THC’s over the last 12 months.
THC's Profit vs Risk Rating (36) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CYH (100). This means that THC’s stock grew somewhat faster than CYH’s over the last 12 months.
THC's SMR Rating (25) in the Hospital Or Nursing Management industry is significantly better than the same rating for CYH (100). This means that THC’s stock grew significantly faster than CYH’s over the last 12 months.
CYH's Price Growth Rating (53) in the Hospital Or Nursing Management industry is in the same range as THC (63). This means that CYH’s stock grew similarly to THC’s over the last 12 months.
THC's P/E Growth Rating (67) in the Hospital Or Nursing Management industry is in the same range as CYH (91). This means that THC’s stock grew similarly to CYH’s over the last 12 months.
| CYH | THC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 74% |
| Advances ODDS (%) | 2 days ago 82% | 8 days ago 81% |
| Declines ODDS (%) | 19 days ago 86% | 6 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 63% |
| Aroon ODDS (%) | N/A | 2 days ago 71% |
Advertisement
CYH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CYH has been loosely correlated with THC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CYH jumps, then THC could also see price increases.
| Ticker / NAME | Correlation To CYH | 1D Price Change % | ||
|---|---|---|---|---|
| CYH | 100% | +0.33% | ||
| THC - CYH | 36% Loosely correlated | +3.58% | ||
| SEM - CYH | 32% Poorly correlated | +0.06% | ||
| SGRY - CYH | 31% Poorly correlated | -0.07% | ||
| OPCH - CYH | 26% Poorly correlated | -3.16% | ||
| UHS - CYH | 26% Poorly correlated | +1.04% | ||
More | ||||
THC and
Correlation & Price change
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.